After Roller Coaster Year, Yidu Stock Settles Down Post-IPO

Big-data healthcare services provider’s operating loss widened in its latest reporting period as revenue grew 62% Key Takeaways: Yidu’s revenue rose 62% in the six months through SeptemberCompany’s health management…

Online Drug Supplier 111 Finds Tonic in B2B Focus

Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…